Exosomal miRNAs—a diagnostic biomarker acting as a guiding light in the diagnosis of prostate cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Genetics,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s10142-022-00951-8.pdf
Reference86 articles.
1. Akoto T, Saini S (2021) Role of exosomes in prostate cancer metastasis. Int J Mol Sci 22(7):3528. https://doi.org/10.3390/ijms22073528
2. Alcayaga-Miranda F, González PL, Lopez-Verrilli A et al (2016) Prostate tumor-induced angiogenesis is blocked by exosomes derived from menstrual stem cells through the inhibition of reactive oxygen species. Oncotarget 7(28):44462–44477. https://doi.org/10.18632/oncotarget.9852
3. Azmi AS, Bao B, Sarkar FH (2013) Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev 32(3–4):623–642. https://doi.org/10.1007/s10555-013-9441-9
4. Banerjee S, Thompson WE, Chowdhury I (2021) Emerging roles of microRNAs in the regulation of Toll-like receptor (TLR)-signaling. Front Biosci (landmark Ed) 26(4):771–796. https://doi.org/10.2741/4917
5. Bertoli G, Cava C, Castiglioni I (2016) MicroRNAs as biomarkers for diagnosis, prognosis and theranostics in prostate cancer. Int J Mol Sci 17(3):421. https://doi.org/10.3390/ijms17030421
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A vivid outline demonstrating the benefits of exosome-mediated drug delivery in CNS-associated disease environments;Archives of Biochemistry and Biophysics;2024-03
2. Harnessing tumor‐derived exosomes: A promising approach for the expansion of clinical diagnosis, prognosis, and therapeutic outcome of prostate cancer;BioFactors;2024-01-11
3. Integrated multiomics analysis of chromosome 19 miRNA cluster in bladder cancer;Functional & Integrative Genomics;2023-08-05
4. MicroRNAs as biomarkers for early diagnosis, targeting and prognosis of prostate cancer;Pathology - Research and Practice;2023-08
5. miR-3133 is an unfavorable prognosis factor and tumor suppressor in colon cancer;Functional & Integrative Genomics;2023-04-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3